{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T01:12:23Z","timestamp":1761959543032,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T00:00:00Z","timestamp":1700265600000},"content-version":"vor","delay-in-days":321,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine Case Reports"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/j.rmcr.2023.101950","type":"journal-article","created":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T13:02:02Z","timestamp":1701090122000},"page":"101950","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Anti-EJ antibody-positive interstitial pneumonia with breast cancer improved by combining immunosuppressive therapy and chemotherapy"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-3653-5334","authenticated-orcid":false,"given":"Ai","family":"Koike","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masako","family":"Arimura-Omori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuyo","family":"Umeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihisa","family":"Takano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Kishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuriko","family":"Takahata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Okamatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akitaka","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taishi","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.rmcr.2023.101950_bib1","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.semarthrit.2020.09.020","article-title":"Antisynthetase syndrome \u2013 much more than just a myopathy","volume":"51","author":"Opinc","year":"2021","journal-title":"Semin. Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.rmcr.2023.101950_bib2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s40257-015-0120-1","article-title":"Cancer risk in dermatomyositis: a meta-analysis of cohort studies","volume":"16","author":"Olazagasti","year":"2015","journal-title":"Am. J. Clin. Dermatol."},{"issue":"34","key":"10.1016\/j.rmcr.2023.101950_bib3","article-title":"Malignancy in dermatomyositis","volume":"99","author":"Chang","year":"2020","journal-title":"Medicine (Baltim.)"},{"issue":"4","key":"10.1016\/j.rmcr.2023.101950_bib4","doi-asserted-by":"crossref","first-page":"278","DOI":"10.5152\/eurjrheum.2017.17036","article-title":"An unusual flare of anti-synthetase syndrome during concurrent trastuzumab therapy given for recurrent breast cancer","volume":"4","author":"Reynolds","year":"2017","journal-title":"Eur. J. Rheumatol."},{"issue":"3","key":"10.1016\/j.rmcr.2023.101950_bib5","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1177\/0394632016651086","article-title":"Aromatase inhibitors and anti-synthetase syndrome","volume":"29","author":"Mascella","year":"2016","journal-title":"Int. J. Immunopathol. Pharmacol."},{"issue":"6","key":"10.1016\/j.rmcr.2023.101950_bib6","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1378\/chest.10-0180","article-title":"Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years?","volume":"138","author":"Connors","year":"2010","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.rmcr.2023.101950_bib7","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/annrheumdis-2012-201800","article-title":"Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients","volume":"73","author":"Aggarwal","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.rmcr.2023.101950_bib8","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2169\/internalmedicine.49.2889","article-title":"Clinical and pathological findings of interstitial lung disease patients with anti-aminoacyl-tRNA synthetase autoantibodies","volume":"49","author":"Koreeda","year":"2010","journal-title":"Intern. Med."},{"key":"10.1016\/j.rmcr.2023.101950_bib9","first-page":"309","volume":"vol. 40","author":"Zanframundo","year":"2023"},{"key":"10.1016\/j.rmcr.2023.101950_bib10","first-page":"1789","article-title":"AB0656 antisynthetase syndrome: CLINICAL value of SOLOMON\u2019S and connors\u2019 diagnosis CRITERIAAnnals of the","volume":"78","author":"Greco","year":"2019","journal-title":"Rheumatic Diseases"},{"issue":"9","key":"10.1016\/j.rmcr.2023.101950_bib11","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.autrev.2014.03.004","article-title":"The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome","volume":"13","author":"Lega","year":"2014","journal-title":"Autoimmun. Rev."},{"issue":"16","key":"10.1016\/j.rmcr.2023.101950_bib12","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.2169\/internalmedicine.3923-19","article-title":"Anti-EJ antibody-positive anti-synthetase syndrome associated with retroperitoneal sarcoma","volume":"59","author":"Fukui","year":"2020","journal-title":"Intern. Med."},{"issue":"1","key":"10.1016\/j.rmcr.2023.101950_bib13","first-page":"21","article-title":"A case of antisynthetase syndrome with anti-EJ antibody complicated by pericarditis","volume":"59","author":"Hayashi","year":"2019","journal-title":"Clin. Neurol."},{"issue":"4","key":"10.1016\/j.rmcr.2023.101950_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060442","article-title":"Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome","volume":"8","author":"Hamaguchi","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.rmcr.2023.101950_bib15","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1093\/rheumatology\/keab166","article-title":"A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies","volume":"60","author":"Oldroyd","year":"2021","journal-title":"Rheumatology"},{"issue":"10","key":"10.1016\/j.rmcr.2023.101950_bib16","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1111\/1759-7714.13168","article-title":"Successful treatment of thymic carcinoma with dermatomyositis and interstitial pneumonia: a case report","volume":"10","author":"Yang","year":"2019","journal-title":"Thorac. Cancer"},{"issue":"3","key":"10.1016\/j.rmcr.2023.101950_bib17","first-page":"438","article-title":"Dermatomyositis and polymyositis associated with malignancy: a 21-year retrospective study","volume":"35","author":"Andr\u00e1s","year":"2008","journal-title":"J. Rheumatol."},{"issue":"August 2019","key":"10.1016\/j.rmcr.2023.101950_bib18","article-title":"Clinical characteristics of patients with anti-EJ antisynthetase syndrome associated interstitial lung disease and literature review","volume":"165","author":"Liu","year":"2020","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmcr.2023.101950_bib19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.rmed.2016.10.019","article-title":"Comprehensive assessment of myositis-specific autoantibodies in polymyositis\/dermatomyositis-associated interstitial lung disease","volume":"121","author":"Hozumi","year":"2016","journal-title":"Respir. Med."},{"issue":"1.2","key":"10.1016\/j.rmcr.2023.101950_bib20","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2152\/jmi.69.107","article-title":"Drug-induced interstitial pneumonia during perioperative chemotherapy for breast cancer","volume":"69","author":"Ikeuchi","year":"2022","journal-title":"J. Med. Invest."},{"issue":"12","key":"10.1016\/j.rmcr.2023.101950_bib21","first-page":"10","article-title":"A case of drug-induced interstitial lung disease caused by epirubicin and cyclophosphamide therapy before breast cancer surgery","volume":"6","author":"Egashira","year":"2021","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.rmcr.2023.101950_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmjresp-2020-000634","article-title":"Predictors of postoperative acute exacerbation of interstitial lung disease: a case-control study","volume":"7","author":"Hosoki","year":"2020","journal-title":"BMJ Open Respir. Res."},{"issue":"9","key":"10.1016\/j.rmcr.2023.101950_bib23","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1007\/s00595-017-1476-z","article-title":"Effect of collagen vascular disease-associated interstitial lung disease on the outcomes of lung cancer surgery","volume":"47","author":"Maeda","year":"2017","journal-title":"Surg. Today"}],"container-title":["Respiratory Medicine Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007123001454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007123001454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T01:07:37Z","timestamp":1761959257000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213007123001454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":23,"alternative-id":["S2213007123001454"],"URL":"https:\/\/doi.org\/10.1016\/j.rmcr.2023.101950","relation":{},"ISSN":["2213-0071"],"issn-type":[{"type":"print","value":"2213-0071"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-EJ antibody-positive interstitial pneumonia with breast cancer improved by combining immunosuppressive therapy and chemotherapy","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmcr.2023.101950","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101950"}}